Vinodh Panjwani

Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia

Murtadha Al‐Khabori, Sunil Bhandari, Mohammed Al-Huneini et al. · Oman Medical Journal · 2013 · 50 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy of Hydroxyurea (HU) in Reduction of Pack Red Cell (PRC) Transfusion Requirement Among Children Having Beta-thalassemia Major: Karachi HU Trial (KHUT)

Saqib Hussain Ansari, Tahir Shamsi, Fahad Javaid Siddiqui et al. · Journal of Pediatric Hematology/Oncology · 2007 · 21 citations

Medicine, Hematology, Pharmacology +17

Levels of regulatory T cells and invariant natural killer cells and their associations with regulatory B�cells in patients with non-Hodgkin lymphoma

Mohamed‐Rachid Boulassel, Zahra Al Qarni, Ikram Burney et al. · Molecular and Clinical Oncology · 2018 · 21 citations · Full text

Life Sciences, Hematology, Immunology +13

Iron Overload in Patients With Heavily Transfused Sickle Cell Disease—Correlation of Serum Ferritin With Cardiac T2* MRI (CMRTools), Liver T2* MRI, and R2-MRI (Ferriscan®)

Salam Alkindi, Vinodh Panjwani, Sarah Al-Rahbi et al. · Frontiers in Medicine · 2021 · 19 citations · Full text

Medicine, Hematology, Radiology +17

Coexistence of sickle cell disease and systemic lupus erythematosus is associated with quantitative and qualitative impairments in circulating regulatory B cells

Mohamed‐Rachid Boulassel, Amal Al-Naamani, Abeer Al-Zubaidi et al. · Human Immunology · 2022 · 12 citations

Life Sciences, Hematology, Immunology +16